SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-4.1
Date Filed: 2026-03-25
Accession Number: 0001213900-26-034072
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026034072/ea028322301ex4-1.htm

Chunk 0 of 3
Word Count: 1490
Character Count: 9145

Document Content:

Exhibit

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, APPLICABLE
STATE SECURITIES LAWS, OR APPLICABLE LAWS OF ANY FOREIGN JURISDICTION. THIS WARRANT AND SUCH UNDERLYING SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE OFFERED, SOLD, PLEDGED, HYPOTHECATED, RENOUNCED OR OTHERWISE
TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS AND
IN THE ABSENCE OF COMPLIANCE WITH APPLICABLE LAWS OF ANY FOREIGN JURISDICTION, OR THE AVAILABILITY OF AN EXEMPTION FROM THE REGISTRATION
PROVISIONS OF THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS.

SYNERGY
CHC CORP.

COMMON
STOCK PURCHASE WARRANT

This Common Stock Purchase
Warrant (the “Warrant”) is issued as of the 24th day of March 2026, by Synergy CHC Corp., a Nevada corporation (the
“Company”), to ACME CREDIT PARTNERS FUND I, LP (the “Holder”). The Holder is a lender under that
certain Term Loan Credit Agreement, dated as of May 30, 2025, as amended (the “Credit Agreement”). All capitalized
terms used herein which are not defined herein shall have the meanings ascribed to them in the Credit Agreement.

1. Issuance
of Warrant; Term; Price.

1.1. Issuance.
Concurrently herewith, the Company is executing a Second Amendment to the Credit Agreement and this Warrant is being issued to
enhance the security of the collateral for the due and punctual payment and performance by the Loan Parties of all of the
Obligations under the Credit Agreement and the other Loan Documents (collectively, the “Secured
Obligations”). In consideration of Holder’s agreement to purchase the Shares, the
Company hereby grants to Holder the right to purchase Three Million (3,000,000) shares of the Company’s common stock (the
“Common Stock”). The shares of Common Stock or other securities for
which this Warrant may be exercisable from time to time shall be referred to herein as the “Warrant Stock.”
The shares of Warrant Stock issuable upon exercise of this Warrant are hereinafter referred to as the
“Shares.” The Company shall register ownership of this Warrant, upon
records to be maintained by the Company for that purpose (the “Warrant Register”),
in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant
is assigned hereunder) from time to time. With a view to making available to the Holder the benefits of Rule 144 and any other rule
or regulation of the Securities and Exchange Commission (the “Commission”)
that may at any time permit a holder to sell securities of the Company to the public without registration or pursuant to a
registration statement, the Company shall: (i) use best efforts to make and keep adequate public information available, as required
by clause (c) of Rule 144, (ii) use best efforts to file with the Commission in a timely manner all reports and other documents
required of the Company under the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and (iii) furnish, or otherwise make available to the Holder so long as the
Holder owns Warrant Stock, promptly upon request, a written statement by the Company as to its compliance with the reporting
requirements of Rule 144 and the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and such other
reports and documents so filed or furnished by the Company as such Holder may reasonably request in connection with the sale of
Common Stock without registration. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof
for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the
contrary.

1.2 Term;
Exercise. This Warrant shall have a term of ten years and will become exercisable
upon a Qualified Event of Default. For purposes of this Warrant, a “Qualified Event of Default” shall mean the occurrence
of any Event of Default under Section 8.1(a) of the Credit Agreement. Upon the occurrence of the indefeasible payment, performance and
satisfaction in full of all Secured Obligations, this Warrant shall terminate.

1.3 Exercise
Price. Subject to adjustment as hereinafter provided, the exercise price (the “Warrant
Price”) per share for which all or any of the Shares may be purchased pursuant to the terms
of this Warrant shall be equal to $0.00001.

2. Adjustment
of Warrant Price, Number and Kind of Shares. The Warrant Price and the number and kind of Shares issuable upon the exercise of this
Warrant shall be subject to adjustment from time to time as follows.

2.1. Dividends
in Stock Adjustment. In case at any time or from time to time on or after the date on which this Warrant is exercisable for Warrant
Stock and while this Warrant is outstanding and unexpired, the holders of the Warrant Stock of the Company (or any shares of stock or
other securities at the time receivable upon the exercise of this Warrant) shall have received, or, on or after the record date fixed
for the determination of eligible stockholders, shall have become entitled to receive, without payment therefor, other or additional
securities or other property (other than cash) of the Company by way of dividend or distribution, then and in each case, the holder of
this Warrant shall, upon the exercise hereof, be entitled to receive, in addition to the number of shares of Warrant Stock receivable
thereupon, and without payment of any additional consideration therefor, the amount of such other or additional securities or other property
(other than cash) of the Company which such holder would have been entitled to receive if it had exercised this Warrant on the date hereof
and thereafter, during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other
additional securities or other property receivable by it as aforesaid during such period, giving effect to all adjustments called for
during such period by this Section 2.

2.2. Reclassification
or Reorganization Adjustment. In case of any changes in the class or kind of securities issuable upon exercise of this Warrant or
any reclassification or change of the outstanding securities of the Company or of any merger, consolidation or reorganization of the
Company (or any other corporation the stock or securities of which are at the time receivable upon the exercise of this Warrant) on or
after the date hereof, then the holder of this Warrant, upon the exercise hereof at any time after the consummation of such reclassification,
change, merger, consolidation or reorganization, shall be entitled to receive, in lieu of the stock or other securities and property
receivable upon the exercise hereof prior to such consummation, the stock or other securities or property to which such holder would
have been entitled upon such consummation if such holder had exercised this Warrant immediately prior thereto, and the Warrant Price
therefore shall be appropriately adjusted, all subject to further adjustment as provided in this Section 2.

2.3. Stock
Splits and Reverse Stock Splits. If at any time on or after the date hereof the Company shall split, subdivide or otherwise change
its outstanding shares of any securities receivable upon exercise of this Warrant into a greater number of shares, the Warrant Price
in effect immediately prior to such subdivision shall thereby be proportionately reduced and the number of shares receivable upon exercise
of this Warrant shall thereby be proportionately increased; and, conversely, if at any time on or after the date hereof the outstanding
number of shares of any securities receivable upon exercise of this Warrant shall be combined into a smaller number of shares, the Warrant
Price in effect immediately prior to such combination shall thereby be proportionately increased and the number of shares receivable
upon exercise of this Warrant shall thereby be proportionately decreased, all subject to further adjustment as provided in this Section

Other Impairment. The Company will not, by amendment of its Certificate of Incorporation or Bylaws or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid
the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of
all such terms and conditions and in the taking of all such action as may be necessary or appropriate in order to protect the rights
of the Holder against impairment.

Fractional Shares. No fractional shares of Warrant Stock will be issued in connection with any exercise hereunder. In lieu of any
fractional shares that would otherwise be issuable, the Company shall pay cash equal to the product of such fraction multiplied by the
fair market value of one share of Warrant Stock on the date of exercise.